ADHD Prescriptions Soar Since Covid Pandemic, Study Reveals
Prescriptions for ADHD stimulants have experienced a dramatic surge since the onset of the Covid-19 pandemic, with new research indicating that virtual screening services and social media influence are significant factors behind this notable rise. A comprehensive study from the University of Toronto has uncovered that prescription numbers for ADHD have doubled in Canada since the pandemic began, with the most substantial increases observed among young adults and women. Similar trends have been documented in the United Kingdom, where both prescriptions and diagnoses for the condition have escalated rapidly in recent years.
Key Findings from the Research
Researchers meticulously analysed data from nearly 330,000 adults in Ontario who were dispensed at least one new prescription for stimulants, which are fast-acting ADHD medications, between 2016 and 2024. The study revealed that more than 220,000 adults received their first course of prescription stimulants in the four years following March 2020, compared to just 107,000 adults in the four years prior to the pandemic. The largest increase and highest rates of new stimulant recipients were identified in young adults, particularly those aged 18 to 24 years old.
Furthermore, the research found that women constituted 59 per cent of adults taking the medication after the pandemic began, despite stimulant prescription rates being relatively similar between men and women before the global health crisis. This shift highlights a significant demographic change in ADHD treatment patterns.
Expert Analysis and Contributing Factors
Dr Mina Tadrous, co-author of the study, explained: "Many of these findings are consistent with trends in stimulant prescribing observed globally in the post-pandemic era and are likely influenced by greater awareness of adult ADHD and improved access to care following a historical pattern of underdiagnosis of ADHD in adulthood — particularly among women." He added: "However, the rising impact of social media influencers on ADHD awareness in young adults, as well as the rapid evolution of virtual health services that support online assessments and treatment, may also be contributing to misdiagnoses and potential harm."
Dr Punit Shah, a psychologist at the University of Bath, noted that while ADHD diagnoses and prescriptions have been increasing for several decades, the UK and most of the world have witnessed a particularly notable rise since the pandemic. A separate study led by the University of Oxford recently found that the number of adults taking ADHD medication has risen twenty-fold since 2010.
Dr Shah commented: "I think the reasons are multifactorial. The increase in diagnosis is partly because of an increase in awareness of ADHD... In terms of other factors, it is speculative, but I think there are theories and ideas that ADHD rates are increasing because people are more willing to seek out diagnosis as well." He suggested that the pandemic provided many individuals with increased time to focus on their internal wellbeing, potentially leading to greater medicalisation of psychological phenomena, including ADHD.
Concerns About Diagnostic Practices
Tara Gomes from the Ontario Drug Policy Research Network expressed cautious optimism mixed with concern: "Our findings may reflect improved recognition and treatment of ADHD in adulthood; however, the speed and scale of this growth also raises important questions about how diagnoses are being made, and if this prescribing is always appropriate." She emphasised: "While greater awareness of adult ADHD has likely supported many people accessing timely care, the speed of rising stimulant prescribing in this population alongside more non-specialist initiation, increasing virtual care, and shorter assessment timelines also raises concerns about the quality of diagnostic practices."
The NHS has been approached for comment regarding these developments and their implications for healthcare services in the United Kingdom. The global rise in ADHD prescriptions continues to spark debate among medical professionals about balancing improved access to care with ensuring accurate diagnoses and appropriate treatment protocols.
